Grant: Engage Grants Program
University of Guelph
$24,040.00
Development of a process for large-scale purification of high-titer GMP-grade virus using NatriFlo HD-Q membrane technology
EF 2016-17
Résumé
Viruses engineered to express antigens to promote a protective immune response against a particular pathogen (vaccine), or to deliver a therapeutic gene (gene therapy) or to treat cancer (oncolytic virotherapy) are essential tools used in the prevention and treatment of diseases in humans and animals. However, a considerable impediment to the use of viruses as vaccines or therapeutic agents is the availability of efficient and scalable production systems. The goal of this project is to design a novel process whereby NatriFlo? HD-Q membrane technology from Natrix Separations can be used to efficiently purify ultra-pure, high titre virus for clinicalapplications. Natrix Separations is a leading supplier of high performance, single use chromatography products to the life science, food, beverage and water markets. Their chromatography is used in a variety of applications including the separation and purification of peptides, proteins, nucleic acids, and monoclonal antibodies. In order to grow their business and expand their applications platform, Natrix Separations is seeking to develop a process whereby their patented separation technology can be used to purify clinical grade viral vaccines or oncolytic viruses for use humans and animals. While Natrix Separations has the chromatographic devices and expertise to optimize purification processes, they do not have the infrastructure (e.g. Containment level 2 laboratory and animal facilities) or the virology expertise necessary to conduct these experiments. Thus, the purpose of this NSERC Engage grant is to facilitate the collaboration of Natrix Separations with an academic virology lab to develop a detailed process for virus purification and to test the activity and purity of the purified viral product in vivo. Upon completion of the project, details of the purification process will be published in an open access peer-reviewed journal. It is anticipated that access to this information will lead to wider acceptance and easier implementation of Natrix Separation technology for virus purification purposes. Since Natrix is a Canadian company, expansion of its applications platform should lead to increased demand for this patentedtechnology and more high tech jobs for Canadians, ultimately benefiting the Canadian economy.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
499834-2016
Name nom
Wootton, Sarah
Department département
Pathobiology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
24040
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
505
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Veterinary pharmaceuticals
Area of application fr
Produits pharmaceutiques à usage vétérinaire
Research subject code
5202
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Virology
Research subject fr
Virologie
Partie
1
Nb partie
1
Application title
Development of a process for large-scale purification of high-titer GMP-grade virus using NatriFlo HD-Q membrane technology
Keyword
NSERC
Application summary
Viruses engineered to express antigens to promote a protective immune response against a particular pathogen (vaccine), or to deliver a therapeutic gene (gene therapy) or to treat cancer (oncolytic virotherapy) are essential tools used in the prevention and treatment of diseases in humans and animals. However, a considerable impediment to the use of viruses as vaccines or therapeutic agents is the availability of efficient and scalable production systems. The goal of this project is to design a novel process whereby NatriFlo? HD-Q membrane technology from Natrix Separations can be used to efficiently purify ultra-pure, high titre virus for clinicalapplications. Natrix Separations is a leading supplier of high performance, single use chromatography products to the life science, food, beverage and water markets. Their chromatography is used in a variety of applications including the separation and purification of peptides, proteins, nucleic acids, and monoclonal antibodies. In order to grow their business and expand their applications platform, Natrix Separations is seeking to develop a process whereby their patented separation technology can be used to purify clinical grade viral vaccines or oncolytic viruses for use humans and animals. While Natrix Separations has the chromatographic devices and expertise to optimize purification processes, they do not have the infrastructure (e.g. Containment level 2 laboratory and animal facilities) or the virology expertise necessary to conduct these experiments. Thus, the purpose of this NSERC Engage grant is to facilitate the collaboration of Natrix Separations with an academic virology lab to develop a detailed process for virus purification and to test the activity and purity of the purified viral product in vivo. Upon completion of the project, details of the purification process will be published in an open access peer-reviewed journal. It is anticipated that access to this information will lead to wider acceptance and easier implementation of Natrix Separation technology for virus purification purposes. Since Natrix is a Canadian company, expansion of its applications platform should lead to increased demand for this patentedtechnology and more high tech jobs for Canadians, ultimately benefiting the Canadian economy.